Organization Overview
Alternative names
autologous mononuclear stem cell (1 trial)
bupropion (wellbutrin) (1 trial)
carboplatin (paraplatin) (4 trials)
cetuximab (erbitux) (2 trials)
cisplatin (platinol) (4 trials)
cyclophosphamide (cytoxan) (4 trials)
doxorubicin (Doxil) (2 trials)
etoposide (vepesid) (2 trials)
fludeoxyglucose f-18 (1 trial)
ipilimumab (yervoy) (6 trials)
levetiracetam (keppra) (1 trial)
allogeneic b-lymphocytes (1 trial)
amitriptyline (elavil) (1 trial)
atezolizumab (Tecentriq) (6 trials)
bevacizumab (avastin) (2 trials)
bifidobacterium animalis (1 trial)
binimetinib (mektovi) (1 trial)
boronophenylalanine-fructose complex (2 trials)
dabrafenib (tafinlar) (1 trial)
durvalumab (imfinzi) (1 trial)
eculizumab (Soliris) (1 trial)
encorafenib (braftovi) (1 trial)
epirubicin (ellence) (3 trials)
fluorouracil (efudex) (3 trials)
lenalidomide (revlimid) (1 trial)
osimertinib (tagrisso) (1 trial)
oxaliplatin (eloxatin) (2 trials)
panitumumab (vectibix) (1 trial)
pazopanib (votrient) (1 trial)
pembrolizumab (keytruda) (2 trials)
Acromegaly (Phase 3)
Adenocarcinoma (Phase 3)
Aggression (Phase 3)
Alcoholism (Phase 4)
Alzheimer Disease (Phase 3)
Anemia, Aplastic (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 2)
Astrocytoma (Phase 3)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Ductal, Breast (Phase 2)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinosarcoma (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Cluster Headache (Phase 3)
Colorectal Neoplasms (Phase 2)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
Coronary Restenosis (Phase 2)
Cough (Phase 2)
Cystic Fibrosis (Phase 2)
Dementia (Phase 3)
Dyspepsia (Phase 3)
Ependymoma (Phase 3)
Esophageal Neoplasms (Phase 3)
Familial Primary Pulmonary Hypertension (Phase 4)
Fibrosis (Phase 2)
Ganglion Cysts (Phase 3)
Gastrointestinal Stromal Tumors (Phase 2)
Glioblastoma (Phase 1)
Graves Disease (Phase 2)
Graves Ophthalmopathy (Phase 2)
Headache (Phase 3)
Head and Neck Neoplasms (Phase 3)
Hemangiosarcoma (Phase 2)
Hodgkin Disease (Phase 2)
Hypertension (Phase 4)
Inflammatory Breast Neoplasms (Phase 2)
Ischemia (Phase 3)
Kidney Diseases (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Medulloblastoma (Phase 3)
Melanoma (Phase 3)
Migraine Disorders (Phase 4)
Mixed Tumor, Mullerian (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myocardial Ischemia (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Nervous System Neoplasms (Phase 1)
Oligodendroglioma (Phase 3)
Opioid-Related Disorders (Phase 2)
Pneumonia (Phase 2)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Recurrence (Phase 3)
Sarcoma (Phase 2)
Schizophrenia (Phase 4)
Stomach Neoplasms (Phase 2)
Thrombocytopenia (Phase 3)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Uveal Neoplasms (Phase 3)